Although recent studies suggest that BATF3 is involved in metabolic disorders, the mechanism by which BATF3 deficiency contributes to the development of metabolic dysfunction-associated fatty liver disease (MASLD) remains unclear. This evidence concerns the gene BATF3 and Other metabolic disease.